BIOMARKER:

BCL2 rearrangement

Entrez ID:

Related biomarkers:

‹

›

BCL2 rearrangement BCL2 rearrangement	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	rituximab Sensitive: C2 – Inclusion Criteria
BCL2 rearrangement BCL2 rearrangement	Lymphoma Lymphoma	multiplex silenced CAR-T therapy Resistant: C3 – Early Trials
BCL2 rearrangement BCL2 rearrangement	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	EPOCH-R Sensitive: C3 – Early Trials

Associations